BASF SE

Discover how BASF’s move toward sustainability, high‑margin specialty chemicals, and a potential Evonik takeover could reshape its future and impact investors.

German chemical giants BASF faces a rebuffed €22‑per‑share bid for Evonik, amid stakeholder scrutiny, Q2 earnings lift, and regulatory uncertainty.

Explore how BASF’s potential bid for Evonik could reshape the specialty‑chemicals market, balancing growth, cost discipline and regulatory shifts.

Explore how BASF’s possible acquisition of Evonik could reshape Europe’s specialty chemicals market, boosting margins, ESG credentials and competitiveness against China.

How BASF’s steady trading and disciplined capital strategy keeps it a stabilizing force in the Euro STOXX 50.

European markets rebound as oil dips below $100 and U.S. yields steady; BASF‑Evonik talks could reshape specialty chemicals, while Kingfisher’s digital shift boosts retail margins.

BASF expands MDI production in Gujarat to meet India’s booming polyurethane market, boosting local supply, reducing logistics costs and driving global growth.

Analyze BASF SE’s chemical‑industry outlook: supply‑chain risks, glyphosate litigation, Fed policy, and competitive pressure reveal hidden value and margin resilience.

German BASF shares dip 1% amid broader chemistry slump, driven by high energy costs, Chinese competition, and volatile raw‑material prices.

Learn how BASF’s 2027 spin‑off of its €10 bn ag‑chemicals unit will unlock value, simplify governance, and boost investor clarity for a sustainable future.